Package 51662-1418-1

Brand: nalbuphine hci

Generic: nalbuphine hci
NDC Package

Package Facts

Identity

Package NDC 51662-1418-1
Digits Only 5166214181
Product NDC 51662-1418
Product ID 51662-1418_2b37c24d-1ab8-34d6-e063-6294a90abf70
Description

1 VIAL, MULTI-DOSE in 1 CARTON (51662-1418-1) / 10 mL in 1 VIAL, MULTI-DOSE

Marketing

Marketing Status
Marketed Since 2019-10-29
Brand nalbuphine hci
Generic nalbuphine hci
Sample Package No

Linked Drug Pages (1)

NALBUPHINE HCI ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["INTRAMUSCULAR", "INTRAVENOUS", "SUBCUTANEOUS"], "spl_id": "2b37c24d-1ab8-34d6-e063-6294a90abf70", "openfda": {"unii": ["ZU4275277R"], "rxcui": ["904440"], "spl_set_id": ["96128b54-24d6-88a3-e053-2a95a90a1c9c"], "manufacturer_name": ["HF Acquisition Co LLC, DBA HealthFirst"]}, "finished": true, "packaging": [{"sample": false, "description": "1 VIAL, MULTI-DOSE in 1 CARTON (51662-1418-1)  / 10 mL in 1 VIAL, MULTI-DOSE", "package_ndc": "51662-1418-1", "marketing_start_date": "20191029"}], "brand_name": "NALBUPHINE HCI", "product_id": "51662-1418_2b37c24d-1ab8-34d6-e063-6294a90abf70", "dosage_form": "INJECTION, SOLUTION", "pharm_class": ["Competitive Opioid Antagonists [MoA]", "Opioid Agonist/Antagonist [EPC]", "Partial Opioid Agonists [MoA]"], "product_ndc": "51662-1418", "generic_name": "NALBUPHINE HCI", "labeler_name": "HF Acquisition Co LLC, DBA HealthFirst", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "NALBUPHINE HCI", "active_ingredients": [{"name": "NALBUPHINE HYDROCHLORIDE", "strength": "20 mg/mL"}], "application_number": "ANDA070918", "marketing_category": "ANDA", "marketing_start_date": "20191029", "listing_expiration_date": "20261231"}